ANTB
CATX icon

AMG National Trust Bank’s Perspective Therapeutics CATX Stock Holding History

AMG National Trust Bank’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,423
Closed -$49.9K – 450
2025
Q1 		$49.9K Sell
23,423
-6,557
-22% -$19.7K ﹤0.01% 439
2024
Q4 		$91.7K Sell
29,980
-7,350
-20% -$60K ﹤0.01% 446
2024
Q3 		$498K Hold
37,330
– – 0.01% 340
2024
Q2 		$372K Hold
37,330
– – 0.01% 367
2024
Q1 		$444K Buy
+37,330
New +$318K 0.01% 345

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AMG National Trust Bank's CATX Position: Q2 2025 in Review

AMG National Trust Bank sold out of Perspective Therapeutics (CATX) in Q2 2025, closing a stake of 23,423 shares — an estimated $49.9K sold.

AMG National Trust Bank first reported a position in CATX in Q1 2024 and held it in 5 quarters. The position peaked at $498K in Q3 2024. 97 funds tracked by Wall St. Rank hold CATX as of Q2 2025.

  • AMG National Trust Bank reported no remaining Perspective Therapeutics position as of Q2 2025 after selling out during the quarter.
  • AMG National Trust Bank sold 23,423 Perspective Therapeutics shares in Q2 2025, an estimated $49.9K.
  • AMG National Trust Bank first reported a position in Perspective Therapeutics in Q1 2024 and held it in 5 quarters.
  • AMG National Trust Bank's Perspective Therapeutics position peaked at $498K in Q3 2024.
  • 97 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2025.

Based on AMG National Trust Bank's 13F filing for Q2 2025, filed 4 Aug 2025.